2508 related articles for article (PubMed ID: 29471030)
1. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
[TBL] [Abstract][Full Text] [Related]
5. Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson's Disease via the TLR4/PI3K/AKT/NF-κB Pathway Stimulated by α-Synuclein.
Zhong Z; Chen W; Gao H; Che N; Xu M; Yang L; Zhang Y; Ye M
Neurochem Res; 2021 Nov; 46(11):3050-3058. PubMed ID: 34347266
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway.
Wang N; Feng BN; Hu B; Cheng YL; Guo YH; Qian H
Food Funct; 2022 Feb; 13(4):2019-2032. PubMed ID: 35103734
[TBL] [Abstract][Full Text] [Related]
7. Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis.
Jing Y; Yu Y; Bai F; Wang L; Yang D; Zhang C; Qin C; Yang M; Zhang D; Zhu Y; Li J; Chen Z
Microbiome; 2021 Mar; 9(1):59. PubMed ID: 33678185
[TBL] [Abstract][Full Text] [Related]
8. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
9. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
[TBL] [Abstract][Full Text] [Related]
10. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-
Zhao Z; Li F; Ning J; Peng R; Shang J; Liu H; Shang M; Bao XQ; Zhang D
Acta Pharm Sin B; 2021 Sep; 11(9):2859-2879. PubMed ID: 34589401
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy.
Kang Y; Kang X; Zhang H; Liu Q; Yang H; Fan W
ASN Neuro; 2021; 13():17590914211016217. PubMed ID: 34053243
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
13. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
14. Microbial treatment: the potential application for Parkinson's disease.
Fang X
Neurol Sci; 2019 Jan; 40(1):51-58. PubMed ID: 30415447
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
16. Fecal Microbiota Transplantation from Aged Mice Render Recipient Mice Resistant to MPTP-Induced Nigrostriatal Degeneration Via a Neurogenesis-Dependent but Inflammation-Independent Manner.
Qiao CM; Zhou Y; Quan W; Ma XY; Zhao LP; Shi Y; Hong H; Wu J; Niu GY; Chen YN; Zhu S; Cui C; Zhao WJ; Shen YQ
Neurotherapeutics; 2023 Sep; 20(5):1405-1426. PubMed ID: 37596429
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation.
Kuai XY; Yao XH; Xu LJ; Zhou YQ; Zhang LP; Liu Y; Pei SF; Zhou CL
Microb Cell Fact; 2021 May; 20(1):98. PubMed ID: 33985520
[TBL] [Abstract][Full Text] [Related]
18. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
Sun J; Li H; Jin Y; Yu J; Mao S; Su KP; Ling Z; Liu J
Brain Behav Immun; 2021 Jan; 91():703-715. PubMed ID: 33148438
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites.
Zhou ZL; Jia XB; Sun MF; Zhu YL; Qiao CM; Zhang BP; Zhao LP; Yang Q; Cui C; Chen X; Shen YQ
Neurotherapeutics; 2019 Jul; 16(3):741-760. PubMed ID: 30815845
[TBL] [Abstract][Full Text] [Related]
20. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
